Insider · CIK 0001570620
Francis Patrick Ostronic
Files at CYTH (Cyclo Therapeutics, Inc.). First filing Apr 24, 2023, latest Apr 24, 2023.
In brief
Francis Patrick Ostronic files SEC Form 4 as director at CYTH (Cyclo Therapeutics, Inc.). Since Apr 24, 2023, Francis Patrick Ostronic has reported 1 open-market buy worth $43k and 0 open-market sells worth $0, the latest filed on Apr 24, 2023.
A track record needs three past buys with six months of prices behind them; Francis Patrick Ostronic has 0, so none is measured yet.
The newest scored trade: bought $43k of CYTH on Apr 20, 2023, filed Apr 24, 2023, scored 42 (moderate).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | Cyclo Therapeutics, Inc. | $43k 59,881 shares | +37% | - |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 27, 2025 | CYTH Cyclo Therapeutics, Inc. | AGrant or award Common Stock | +70,329 | $0.00 | $0 | 419,100 | Mar 3, 2025 |
| Jun 3, 2024 | CYTH Cyclo Therapeutics, Inc. | AGrant or award Common Stock | +10,743 | $0.00 | $0 | 348,771 | Jun 5, 2024 |
| Jun 3, 2024 | CYTH Cyclo Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +15,562 | $0.00 | $0 | 15,562 | Jun 5, 2024 |
| Feb 13, 2024 | CYTH Cyclo Therapeutics, Inc. | AGrant or award Common Stock | +8,703 | $0.00 | $0 | 338,028 | Feb 15, 2024 |
| Nov 28, 2023 | CYTH Cyclo Therapeutics, Inc. | AGrant or award Common Stock | +10,262 | $0.00 | $0 | 329,325 | Nov 30, 2023 |
| Oct 20, 2023 | CYTH Cyclo Therapeutics, Inc. | XIn-the-money exercise Common Stock | +59,881 | $0.71 | $43k | 308,952 | Oct 23, 2023 |
| Oct 20, 2023 | CYTH Cyclo Therapeutics, Inc. | XIn-the-money exercise Warrant to Purchase Common Stockderivative | -59,881 | $0.13 | $7,485 | 0 | Oct 23, 2023 |
| Oct 20, 2023 | CYTH Cyclo Therapeutics, Inc. | POpen-market purchase Warrant to Purchase Common Stockderivative | +65,869 | - | - | 65,869 | Oct 23, 2023 |
| May 17, 2023 | CYTH Cyclo Therapeutics, Inc. | AGrant or award Common Stock | +26,700 | $0.00 | $0 | 249,071 | May 18, 2023 |
| Apr 20, 2023 | CYTH Cyclo Therapeutics, Inc. | POpen-market purchase Common Stock | +59,881 | $0.71 | $43k | 222,371 | Apr 24, 2023 |
| Apr 20, 2023 | CYTH Cyclo Therapeutics, Inc. | POpen-market purchase Warrant to Purchase Common Stockderivative | +59,881 | $0.13 | $7,485 | 59,881 | Apr 24, 2023 |
| Mar 7, 2023 | CYTH Cyclo Therapeutics, Inc. | AGrant or award Stock Option (Right to buy)derivative | +3,350 | $0.00 | $0 | 3,350 | Mar 9, 2023 |
| Nov 8, 2022 | CYTH Cyclo Therapeutics, Inc. | AGrant or award Common Stock | +11,803 | $0.00 | $0 | 162,490 | Nov 9, 2022 |
Questions about Francis Patrick Ostronic
Answered from the filings on this page, as of the latest one.
Is Francis Patrick Ostronic buying or selling?
Not in the last 12 months. Francis Patrick Ostronic's latest open-market trade on SEC Form 4 was bought $43k of CYTH on Apr 20, 2023.
How did Francis Patrick Ostronic's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Francis Patrick Ostronic has 0.
Where does Francis Patrick Ostronic file Form 4?
Francis Patrick Ostronic has filed Form 4 at CYTH (Cyclo Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.